MacroGenics Inc. (MGNX)

16.06
NASDAQ : Health Technology
Prev Close 15.22
Day Low/High 15.22 / 16.10
52 Wk Low/High 9.87 / 32.32
Avg Volume 840.50K
Exchange NASDAQ
Shares Outstanding 48.81M
Market Cap 742.83M
EPS -4.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

3 Promising Small Biotech Stocks to Watch

3 Promising Small Biotech Stocks to Watch

I think there is still upside left in a variety of smaller names especially if M&A activity picks up across the industry.

MGNX Makes Notable Cross Below Critical Moving Average

MGNX Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of MacroGenics, Inc crossed below their 200 day moving average of $18.98, changing hands as low as $18.61 per share. MacroGenics, Inc shares are currently trading down about 0.6% on the day.

MacroGenics Stock Soars on Positive Breast Cancer Trial Results

MacroGenics Stock Soars on Positive Breast Cancer Trial Results

Its positive Phase 3 results of Sophia, a study on the efficacy of margetuximab in patents with HER2-positive metastatic breast cancer, is sending the stock soaring.

MacroGenics Enters Oversold Territory (MGNX)

MacroGenics Enters Oversold Territory (MGNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

February 2019 Options Now Available For MacroGenics (MGNX)

February 2019 Options Now Available For MacroGenics (MGNX)

Investors in MacroGenics, Inc saw new options begin trading today, for the February 2019 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MGNX options chain for the new February 2019 contracts and identified one put and one call contract of particular interest.

MacroGenics Becomes Oversold (MGNX)

MacroGenics Becomes Oversold (MGNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of November 16th Options Trading For MacroGenics (MGNX)

First Week Of November 16th Options Trading For MacroGenics (MGNX)

Investors in MacroGenics, Inc saw new options become available this week, for the November 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MGNX options chain for the new November 16th contracts and identified the following put contract of particular interest.

MGNX Makes Notable Cross Below Critical Moving Average

MGNX Makes Notable Cross Below Critical Moving Average

In trading on Friday, shares of MacroGenics, Inc crossed below their 200 day moving average of $22.41, changing hands as low as $21.58 per share. MacroGenics, Inc shares are currently trading down about 2.4% on the day.

MacroGenics Breaks Above 200-Day Moving Average - Bullish For MGNX

MacroGenics Breaks Above 200-Day Moving Average - Bullish For MGNX

In trading on Thursday, shares of MacroGenics, Inc crossed above their 200 day moving average of $21.59, changing hands as high as $22.06 per share. MacroGenics, Inc shares are currently trading up about 4% on the day.

First Week Of MGNX August 17th Options Trading

First Week Of MGNX August 17th Options Trading

Investors in MacroGenics, Inc saw new options become available this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MGNX options chain for the new August 17th contracts and identified one put and one call contract of particular interest.

Arconic Is Showing a Few Dents, Plus 4 Other Stocks That Look Good Short

ARNC, IVZ, MGNX, RRGB and BMS were all recently downgraded by TheStreet's Quant Ratings service.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACXM, HPP, HY, IDTI, NTAP, PCTY, POWI, RL, SNPS, SYNT, UBNT, WES Downgrades: MGNX, RRGB, UHT, WK Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

MacroGenics Is Now Oversold (MGNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

5 Small-Cap Stocks With Explosive Upside Potential

5 Small-Cap Stocks With Explosive Upside Potential

These five stocks may be small but top analysts see big potential ahead. Here are the names you must know about.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: MGNX Downgrades: C, CMCT, CSWI, GM, GOOD, KALU, ODC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

First Week of May 18th Options Trading For MacroGenics (MGNX)

First Week of May 18th Options Trading For MacroGenics (MGNX)

Investors in MacroGenics, Inc saw new options begin trading this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MGNX options chain for the new May 18th contracts and identified one put and one call contract of particular interest.

MacroGenics Reaches Analyst Target Price

MacroGenics Reaches Analyst Target Price

In recent trading, shares of MacroGenics, Inc have crossed above the average analyst 12-month target price of $30.00, changing hands for $31.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

February Trade Ideas Rundown: How'd We Do?

February Trade Ideas Rundown: How'd We Do?

A fresh look at all 17 ideas: the winners, the losers and the still to be determined.

Play MacroGenics for a Potential Pop

Play MacroGenics for a Potential Pop

I don't think MGNX has quite the same upside as IFRX, but a push above $23.50 should spur buying.

MacroGenics Announces Continuation Of SOPHIA Study Of Margetuximab Based On Completion Of Interim Futility Analysis

MacroGenics Announces Continuation Of SOPHIA Study Of Margetuximab Based On Completion Of Interim Futility Analysis

FDA grants Fast Track designation to margetuximab for treatment of metastatic breast cancer

TheStreet Quant Rating: D (Sell)